Nanollose Ltd (ASX: NC6) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Nanollose Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$22.12 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
325.35 million
Earnings per share
-0.007
Dividend per share
N/A
Year To Date Return
32.65%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Nanollose Ltd (ASX: NC6)
Latest News
Share Market News
Why the Nanollose (ASX:NC6) share price is shooting higher today
NC6 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Nanollose Ltd
Nanollose Ltd is a biomaterials company, commercialising technology to create fibres, fabrics, and other materials with minimal environmental impact. Its principal activities include research and development, and promotion of the Company'smicrobial cellulose technologies. The company is engaged in development and commercialization of its Tree-Free rayon fibre for use in textiles (Nullarbor) and non-woven applications (Nufolium).
NC6 Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 16 Jan 2026 | $0.07 | $0.00 | 0.00% | 273,290 | $0.06 | $0.07 | $0.06 |
| 15 Jan 2026 | $0.06 | $0.00 | 0.00% | 232,555 | $0.06 | $0.07 | $0.06 |
| 14 Jan 2026 | $0.06 | $0.01 | 18.87% | 226,451 | $0.06 | $0.06 | $0.06 |
| 13 Jan 2026 | $0.05 | $-0.01 | -16.95% | 190,051 | $0.06 | $0.06 | $0.05 |
| 12 Jan 2026 | $0.06 | $0.00 | 0.00% | 61,540 | $0.06 | $0.06 | $0.06 |
| 09 Jan 2026 | $0.06 | $0.00 | 0.00% | 89,633 | $0.06 | $0.06 | $0.06 |
| 08 Jan 2026 | $0.06 | $0.01 | 20.00% | 65,676 | $0.05 | $0.06 | $0.05 |
| 07 Jan 2026 | $0.05 | $0.00 | 0.00% | 253,075 | $0.05 | $0.05 | $0.05 |
| 06 Jan 2026 | $0.05 | $0.00 | 0.00% | 201,509 | $0.05 | $0.05 | $0.05 |
| 05 Jan 2026 | $0.05 | $0.00 | 0.00% | 354,913 | $0.05 | $0.05 | $0.05 |
| 02 Jan 2026 | $0.05 | $0.00 | 0.00% | 202 | $0.05 | $0.05 | $0.05 |
| 31 Dec 2025 | $0.05 | $0.00 | 0.00% | 76,792 | $0.05 | $0.05 | $0.05 |
| 30 Dec 2025 | $0.05 | $0.00 | 0.00% | 170,420 | $0.05 | $0.05 | $0.05 |
| 29 Dec 2025 | $0.05 | $0.00 | 0.00% | 14,000 | $0.05 | $0.05 | $0.05 |
| 23 Dec 2025 | $0.05 | $0.00 | 0.00% | 51,899 | $0.05 | $0.05 | $0.05 |
| 22 Dec 2025 | $0.05 | $0.00 | 0.00% | 277,994 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Dec 2025 | Heidi Beatty | Issued | 1,000,000 | $40,000 |
Issue of options.
|
| 01 Aug 2025 | Andrew Moullin | Buy | 100,000 | $8,300 |
On-market trade.
|
| 27 Feb 2025 | Winton Willesee | Issued | 12,500,000 | $200,000 |
Director remuneration. As per announcement on 05-03-2025
|
| 27 Feb 2025 | Winton Willesee | Issued | 3,117,901 | $62,358 |
Rights issue.
|
| 27 Feb 2025 | Winton Willesee | Issued | 3,089,500 | $49,432 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Winton William Willesee | Non-Executive Director | Sep 2014 |
Mr Willesee is an experienced company director with over 20 years' experience in multiple roles within the Australian capital markets. He has experience with ASX listed and other companies over a range of industries having been involved with ventures from early stage through to capital development projects. He has a core expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance.
|
| Dr Wayne Morris Best | Executive ChairmanExecutive Director | Sep 2014 |
Dr Best has 40 years' experience in organic chemistry both in academia, government and industry. He spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd.
|
| Ms Heidi Beatty | Non-Executive Director | Jul 2019 |
Ms Beatty, founder of Crown Abbey Ltd is a scientist and innovator who has 20 years' experience developing consumer and health care products. In 2015 Heidi founded Crown Abbey Ltd, a consultancy company that supports clients in their project launches, combining Project Management and Product Development across Consumer and Healthcare categories.
|
| Mr Andrew Moullin | Non-Executive Director | Jul 2025 |
Mr Moullin is an experienced executive with over two decades in legal, commercial, and corporate leadership roles. He brings expertise in strategic project execution, complex commercial negotiations, and robust corporate governance. Andrew has held senior roles at Iluka Resources Limited, DLA Piper, Macro Metals Limited, Fivemark Partners and CLSA, as well as founding and managing a range of other businesses. His expertise encompasses M&A, project planning and execution, capital raisings, and investor relations initiatives.
|
| Mrs Erlyn Dawson | Company Secretary |
-
|
|
| Erlyn Dawson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Netwealth Investments Limited <Wrap Services A/C> | 25,061,048 | 8.21% |
| Conbrio Beteiligungen AG | 20,625,000 | 6.75% |
| Wayne Morris Best <Wayne & Debra Best Fam A/C> | 20,225,002 | 6.62% |
| Gleneagle Securities Nominees Pty Limited | 14,375,000 | 4.71% |
| Chincherinchee Nominees Pty Ltd | 12,500,000 | 4.09% |
| Azalea Family Holdings Pty Ltd <No 2 A/C> | 12,358,006 | 4.05% |
| Spinite Pty Ltd | 9,580,000 | 3.14% |
| Diamond Construct Pty Ltd | 7,500,000 | 2.46% |
| Invia Custodian Pty Limited <The Fry Family A/C> | 6,572,909 | 2.15% |
| Mr Jason Duncan Maclaurin | 6,351,190 | 2.08% |
| Citicorp Nominees Pty Limited | 5,992,302 | 1.96% |
| Mr John Moursounidis <Moursounidis Family A/C> | 5,934,523 | 1.94% |
| The Key Company Pty Ltd | 5,166,667 | 1.69% |
| Mr Jason Stephen Tincey & Mrs Holly Elise Tincey <Stellas Treasure A/C> | 4,013,131 | 1.31% |
| Challen 7 Pty Ltd <Pashro Unit A/C> | 3,994,287 | 1.31% |
| Madeiros Pty Ltd <Visser Super Fund A/C> | 3,805,015 | 1.25% |
| Mr Andreas Steinwachs | 3,666,667 | 1.20% |
| Mr Dean Anthony Mackenzie | 3,481,540 | 1.14% |
| Dutch Ink (2010) Pty Ltd | 3,047,875 | 1.00% |
| Tripit Pty Ltd <Peter Heather Wells S/F A/C> | 3,000,000 | 0.98% |
